This session explores complex coronary challenges and anatomical anomalies encountered in clinical practice. Topics include management of thrombus showers from unexpected culprits, ultra-low contrast angioplasty in mesenteric ischemia, advanced bifurcation PCI techniques with IVUS guidance, and troubleshooting difficult stent delivery scenarios in calcified lesions and challenging...

Focus on the evolving role of drug-coated balloons (DCB) in complex PCI, extending their use beyond traditional indications to challenging coronary lesions and high-risk patient populations. This session reviews clinical data from the SCAAR Prevail registry and discusses the evidence journey supporting broader advocacy for DCB...

Addressing current challenges in complex coronary interventions, this session covers management strategies for CHIP patients, advanced techniques for highly calcified lesions, and principles for mechanical circulatory support application in high-risk PCI scenarios. It offers practical insights and case-based discussions to optimize safety and efficacy in contemporary...

Discover the list of all the Andreas Grüntzig Ethica Awardees.

Professor Roberto Ferrari presented the results of the ATPCI trial on Sunday, August 30th, in a Hot Line session of the ESC Congress 2020 The Digital Experience. Dejan Milasinovic provides his analysis of this study.

A 61-year-old man with a history of 2-vessel coronary artery stenting, hypertension and type-2 diabetes mellitus was admitted 5 times within September 2017 and November 2018 for recurrent angina CCS class III-IV refractory to therapy with nitrates, b-blockers and ranolazine in maximally tolerated doses...

Pulmonary artery rupture during right catheterization is a serious complication that needs to be solved urgently. The patient can be stabilized by tamponade of the pulmonary artery with the catheter balloon tip, as demonstrated in this image in cardiology.

In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.

EuroPCR – the 2023 edition – has been prepared with a new Core Team. Indeed, Jean Fajadet and William Wijns invited three new Course Directors to join them in this role at the end of last year. It was all part of a general reorganisation of PCR’s structure, during...

Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.